# FDA Inspection 1066751 - Avara Pharmaceutical Technologies, Inc. - September 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/avara-pharmaceutical-technologies-inc/29f4473c-c275-40ce-a917-6b0c5fbe4f4d
Source feed: FDA_Inspections

> FDA Inspection 1066751 for Avara Pharmaceutical Technologies, Inc. on September 26, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1066751
- Company Name: Avara Pharmaceutical Technologies, Inc.
- Inspection Date: 2018-09-26
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1192124 - 2022-10-31](https://www.keypedia.com/records/fda_inspections/avara-pharmaceutical-technologies-inc/a61728e1-15e0-451b-9b67-3ea6b39916a8)
- [FDA Inspection 773884 - 2012-03-30](https://www.keypedia.com/records/fda_inspections/avara-pharmaceutical-technologies-inc/777ba4b4-0375-459a-b800-37d7c15a0c54)
- [FDA Inspection 683863 - 2010-09-27](https://www.keypedia.com/records/fda_inspections/avara-pharmaceutical-technologies-inc/bf254822-9bd4-489c-86c9-15d0e7a73028)

Company: https://www.keypedia.com/companies/avara-pharmaceutical-technologies-inc/c685fa1d-522c-462d-a1d8-f32badd44e8d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c